WO2011139832A3 - Method for treating mycobacterial infections - Google Patents
Method for treating mycobacterial infections Download PDFInfo
- Publication number
- WO2011139832A3 WO2011139832A3 PCT/US2011/034319 US2011034319W WO2011139832A3 WO 2011139832 A3 WO2011139832 A3 WO 2011139832A3 US 2011034319 W US2011034319 W US 2011034319W WO 2011139832 A3 WO2011139832 A3 WO 2011139832A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mycobacterial infections
- treating mycobacterial
- mediated
- mycobacteria
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Abstract
The present invention relates to methods for treating mycobacterial infections, for example infections caused or mediated by Mycobacterium tuberculosis or nontuberculous mycobacteria and in particular those infections caused or mediated by resistant or highly virulent strains of mycobacteria, using a safe and effective amount of an antibiotic compound.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32877510P | 2010-04-28 | 2010-04-28 | |
US61/328,775 | 2010-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011139832A2 WO2011139832A2 (en) | 2011-11-10 |
WO2011139832A3 true WO2011139832A3 (en) | 2012-04-05 |
Family
ID=44904382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/034319 WO2011139832A2 (en) | 2010-04-28 | 2011-04-28 | Method for treating mycobacterial infections |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011139832A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016061772A1 (en) | 2014-10-22 | 2016-04-28 | Merck Sharp & Dohme Corp. | Nargenicin compounds and uses thereof as antibacterial agents |
MX2017006319A (en) * | 2014-11-14 | 2017-08-10 | Melinta Therapeutics Inc | Method for treating, preventing, or reducing the risk of skin infection. |
EP4324824A2 (en) * | 2015-10-14 | 2024-02-21 | The Global Alliance for TB Drug Development, Inc. | Combination antibacterial composition and short-course antibacterial regimen |
US20170333400A1 (en) * | 2016-05-17 | 2017-11-23 | Melinta Therapeutics, Inc. | Topical formulations of biaryl heterocyclic compounds and methods of use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007133803A2 (en) * | 2006-05-15 | 2007-11-22 | Rib-X Pharmaceuticals, Inc. | Treatment of mycobacterial infections |
WO2008085913A1 (en) * | 2007-01-04 | 2008-07-17 | Rib-X Pharmaceuticals, Inc. | Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
-
2011
- 2011-04-28 WO PCT/US2011/034319 patent/WO2011139832A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007133803A2 (en) * | 2006-05-15 | 2007-11-22 | Rib-X Pharmaceuticals, Inc. | Treatment of mycobacterial infections |
WO2008085913A1 (en) * | 2007-01-04 | 2008-07-17 | Rib-X Pharmaceuticals, Inc. | Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
Non-Patent Citations (3)
Title |
---|
FORTUN J. ET AL.: "Linezolid for the treatment of multidrug-resistant tuberculosis", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 56, 2005, pages 180 - 185 * |
SKRIPKIN, E. ET AL.: "Rd-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 52, no. 10, 2008, pages 3550 - 3557 * |
ZHOU, J. ET AL.: "Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics", BIOORGANIC& MEDICINAL CHEMISTRY LETTERS, vol. 18, 2008, pages 6175 - 6178, XP025646301, DOI: doi:10.1016/j.bmcl.2008.10.011 * |
Also Published As
Publication number | Publication date |
---|---|
WO2011139832A2 (en) | 2011-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ749872A (en) | Compositions comprising bacterial strains | |
WO2012145491A3 (en) | Composition and method for enhancing an immune response | |
WO2009109532A9 (en) | Use of defensins against tuberculosis | |
WO2014086749A3 (en) | Composition comprising a biological control agent and an insecticide | |
SI2788512T1 (en) | Composition of bacterial strains, bioremediation mixture and use of this composition for the removal of contaminants from the soil and a method for purifying of the soil contaminants | |
EP3533885A4 (en) | Annealing separator composition for oriented electrical steel sheet, oriented electrical steel sheet, and method for manufacturing oriented electrical steel sheet | |
WO2012064806A3 (en) | Methods and compositions for unsilencing imprinted genes | |
WO2014063704A3 (en) | M. tuberculosis vaccines | |
WO2012148880A3 (en) | A method for the preparation of doped single graphene sheets | |
GB201015717D0 (en) | Apparatus for gripping a chain | |
EP3561084A4 (en) | Annealing separator composition for oriented electrical steel sheet, oriented electrical steel sheet, and method for manufacturing oriented electrical steel sheet | |
EP3561085A4 (en) | Annealing separator composition for oriented electrical steel sheet, oriented electrical steel sheet, and method for manufacturing oriented electrical steel sheet | |
WO2012097185A3 (en) | Omv vaccine against burkholderia infections | |
EP2977465A4 (en) | Selective detection method for mycobacterium tuberculosis and nontuberculous mycobacteria and kit using same | |
EP2677025A4 (en) | Novel sphingomonas sp. microorganism, and method for decomposing methane or odor-producing compounds using same | |
EP2602349A4 (en) | High carbon chromium bearing steel, and preparation method thereof | |
EP3561086A4 (en) | Annealing separator composition for grain-oriented electrical steel sheet, grain-oriented electrical steel sheet, and method for producing grain-oriented electrical steel sheet | |
EP3225701A4 (en) | Annealing separator composition for oriented electrical steel sheet, and method for manufacturing oriented electrical steel sheet using same | |
MX2014000920A (en) | Method for evaluating bacterial cell wall integrity. | |
WO2011139832A3 (en) | Method for treating mycobacterial infections | |
EP3438292A4 (en) | Magnesium oxide for annealing separators, and grain-oriented magnetic steel sheet | |
EP3438324A4 (en) | Magnesium oxide for annealing separators, and grain-oriented magnetic steel sheet | |
WO2014066903A8 (en) | Biocontrol of nematodes | |
ZA201702091B (en) | Compositions and methods for treating an active mycobacterium tuberculosis infection | |
EP4194580A4 (en) | Steel, steel structural member, electronic device, steel structural member preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11778008 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11778008 Country of ref document: EP Kind code of ref document: A2 |